Sprecher, Dennis L.

Association of Nitrotyrosine Levels With Cardiovascular Disease and Modulation by Statin Therapy

Shishehbor, M. H., Aviles, R. J., Brennan, M.-L., Fu, X., Goormastic, M., Pearce, G. L., Gokce, N., Keaney, J. F., Penn, M. S., Sprecher, D. L., et al. (2003) · JAMA

Nitric Oxide and Endothelin EffectsLipoproteins and Cardiovascular Health

Cited by 464

Circulating Fibroblast Growth Factor 21 Is Induced by Peroxisome Proliferator-Activated Receptor Agonists But Not Ketosis in Man

Christodoulides, C., Dyson, P., Sprecher, D., Tsintzas, K., & Karpe, F. (2009) · The Journal of Clinical Endocrinology & Metabolism

Fibroblast Growth Factor ResearchPeroxisome Proliferator-Activated Receptors

Cited by 153

Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males

Mitchell, L. E., Sprecher, D. L., Borecki, I. B., Rice, T., Laskarzewski, P. M., & Rao, D. C. (1994) · Circulation

Hormonal and reproductive studiesAcute Myocardial Infarction Research

Cited by 116

Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia.

Mann, W. A., Gregg, R. E., Sprecher, D. L., & Brewer, H. B. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 75